Literature DB >> 21448423

Prognostic factors of T4 gastric cancer patients undergoing potentially curative resection.

Naoto Fukuda1, Yasuyuki Sugiyama, Joji Wada.   

Abstract

AIM: To investigate the prognostic factors of T4 gastric cancer patients without distant metastasis who could undergo potentially curative resection.
METHODS: We retrospectively analyzed the clinical data of 71 consecutive patients diagnosed with T4 gastric cancer and who underwent curative gastrectomy at our institutions. The clinicopathological factors that could be associated with overall survival were evaluated. The cumulative survival was determined by the Kaplan-Meier method, and univariate comparisons between the groups were performed using the log-rank test. Multivariate analysis was performed using the Cox proportional hazard model and a step-wise procedure.
RESULTS: The study patients comprised 53 men (74.6%) and 18 women (25.4%) aged 39-89 years (mean, 68.9 years). Nineteen patients (26.8%) had postoperative morbidity: pancreatic fistula developed in 6 patients (8.5%) and was the most frequent complication, followed by anastomosis stricture in 5 patients (7.0%). During the follow-up period, 28 patients (39.4%) died because of gastric cancer recurrence, and 3 (4.2%) died because of another disease or accident. For all patients, the estimated overall survival was 34.1% at 5 years. Univariate analyses identified the following statistically significant prognostic factors in T4 gastric cancer patients who underwent potentially curative resection: peritoneal washing cytology (P < 0.01), number of metastatic lymph nodes (P < 0.05), and venous invasion (P < 0.05). In multivariate analyses, only peritoneal washing cytology was identified as an independent prognostic factor (HR = 3.62, 95% CI = 1.37-9.57) for long-term survival.
CONCLUSION: Positive peritoneal washing cytology was the only independent poor prognostic factor for T4 gastric cancer patients who could be treated with potentially curative resection.

Entities:  

Keywords:  Gastric cancer; Peritoneal cytology; Prognostic factors; T4; Venous invasion

Mesh:

Year:  2011        PMID: 21448423      PMCID: PMC3063911          DOI: 10.3748/wjg.v17.i9.1180

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Prognostic factors in patients with advanced gastric cancer with macroscopic invasion to adjacent organs treated with radical surgery.

Authors:  Hiroshi Isozaki; Noriaki Tanaka; Nobuhiro Tanigawa; Kunio Okajima
Journal:  Gastric Cancer       Date:  2000-12       Impact factor: 7.370

2.  Peritoneal lavage cytology and carcinoembryonic antigen determination in predicting peritoneal metastasis and prognosis of gastric cancer.

Authors:  Ji-Kun Li; Miao Zheng; Chuan-Wen Miao; Jian-Hai Zhang; Guang-Han Ding; Wen-Shen Wu
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 3.  Epidemiology of gastric cancer.

Authors:  A I Neugut; M Hayek; G Howe
Journal:  Semin Oncol       Date:  1996-06       Impact factor: 4.929

4.  Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences.

Authors:  M La Torre; M Ferri; M R Giovagnoli; N Sforza; G Cosenza; E Giarnieri; V Ziparo
Journal:  Eur J Surg Oncol       Date:  2010-07-01       Impact factor: 4.424

5.  Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cancer cells.

Authors:  C C Wu; J T Chen; M C Chang; W L Ho; C Y Chen; D C Yeh; T J Liu; F K P'eng
Journal:  J Am Coll Surg       Date:  1997-06       Impact factor: 6.113

6.  The efficacy of gastrectomy for large gastric cancer.

Authors:  Osamu Kobayashi; Akira Tsuburaya; Takaki Yoshikawa; Tomohiko Osaragi; Hitoshi Murakami; Tatsuya Yoshida; Motonori Sairenji
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

7.  Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.

Authors:  E Bando; Y Yonemura; Y Takeshita; K Taniguchi; T Yasui; Y Yoshimitsu; S Fushida; T Fujimura; G Nishimura; K Miwa
Journal:  Am J Surg       Date:  1999-09       Impact factor: 2.565

8.  Extended local resection for advanced gastric cancer: increased survival versus increased morbidity.

Authors:  Robert C G Martin; David P Jaques; Murray F Brennan; Martin Karpeh
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

9.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

Review 10.  Molecular pathology of tumor metastasis. II. Molecular staging and differential diagnosis.

Authors:  József Tímár; Orsolya Csuka; Zsolt Orosz; András Jeney; László Kopper
Journal:  Pathol Oncol Res       Date:  2003-01-06       Impact factor: 3.201

View more
  11 in total

1.  Surgery for Locally Advanced GIT Cancers Has Potentially Good Postoperative Outcomes in a Tertiary Hospital.

Authors:  Anwar Tawfik Amin; Ahmed A S Salem; Abeer Ibrahim
Journal:  J Gastrointest Cancer       Date:  2020-03

2.  Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study.

Authors:  Antanas Mickevicius; Povilas Ignatavicius; Rytis Markelis; Audrius Parseliunas; Dainora Butkute; Mindaugas Kiudelis; Zilvinas Endzinas; Almantas Maleckas; Zilvinas Dambrauskas
Journal:  BMC Surg       Date:  2014-11-26       Impact factor: 2.102

3.  CA125 is a potential biomarker to predict surgically incurable gastric and cardia cancer: A retrospective study.

Authors:  Taobo Luo; Wenhu Chen; Lifang Wang; Hongguang Zhao
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

Review 4.  Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysis.

Authors:  Francisco Tustumi; Wanderley Marques Bernardo; Andre Roncon Dias; Marcus Fernando Kodama Pertille Ramos; Ivan Cecconello; Bruno Zilberstein; Ulysses Ribeiro-Júnior
Journal:  Clinics (Sao Paulo)       Date:  2016-12-01       Impact factor: 2.365

5.  Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection.

Authors:  Bao-Yan Zhu; Shu-Qiang Yuan; Run-Cong Nie; Shu-Man Li; Li-Rong Yang; Jin-Ling Duan; Ying-Bo Chen; Xiao-Shi Zhang
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

6.  Incidence, Risk Factors and Prognosis of T4a Gastric Cancer: A Population-Based Study.

Authors:  Zhiya Hu; Ziyi Zuo; Han Miao; Zhijie Ning; Youyuan Deng
Journal:  Front Med (Lausanne)       Date:  2022-01-05

7.  Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma.

Authors:  Rebecca Zhu; Fangfang Liu; Gabriella Grisotti; Javier Perez-Irizarry; Ronald R Salem; Charles H Cha; Kimberly L Johung; Daniel J Boffa; Yawei Zhang; Sajid A Khan
Journal:  J Gastrointest Oncol       Date:  2018-06

8.  Surgical outcomes and prognostic factors of T4 gastric cancer patients without distant metastasis.

Authors:  Ming-zhe Li; Liang Deng; Jing-jing Wang; Long-bin Xiao; Wen-hui Wu; Shi-bin Yang; Wen-feng Li
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

Review 9.  Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis.

Authors:  Mathieu Pecqueux; Johannes Fritzmann; Mariam Adamu; Kristian Thorlund; Christoph Kahlert; Christoph Reißfelder; Jürgen Weitz; Nuh N Rahbari
Journal:  Oncotarget       Date:  2015-11-03

10.  Bursectomy and non-bursectomy D2 gastrectomy for advanced gastric cancer, initial experience from a single institution in China.

Authors:  Wei-Han Zhang; Xin-Zu Chen; Kun Yang; Kai Liu; Zhi-Xin Chen; Bo Zhang; Zong-Guang Zhou; Jian-Kun Hu
Journal:  World J Surg Oncol       Date:  2015-12-08       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.